United States · FDA National Drug Code directory
Posaconazole
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72319-023_3249c585-7620-444f-e063-6294a90ae5ac
- Product NDC
- 72319-023
- Form
- TABLET, DELAYED RELEASE
- Composition / generic term
- Posaconazole
- Labeler
- i3 Pharmaceuticals, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230915
- Source listing expiry
- 20261231
Source-listed ingredients
- POSACONAZOLE — 100 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 60 TABLET, DELAYED RELEASE in 1 BOTTLE (72319-023-02) · 72319-023-02
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →